RESEARCH DOSSIER
Preventive Care, Screening, and Health Service Uptake
Abstract. Preventive service uptake is the sequence through which eligible people encounter, evaluate, begin, and complete an evidence-supported offer of screening, vaccination, or preventive counseling. This critical narrative research synthesis examines the development of health behavior and service-access models, the roles of perceived benefit, threat, self-efficacy, trust, health literacy, and opportunity, and randomized evidence from colorectal cancer screening, cervical HPV self-collection, vaccine communication, and text-message reminders. It distinguishes one-time initiation from clinically complete and repeated preventive pathways, and service participation from proven net clinical benefit. Evidence is interpreted using causal-inference and implementation-science principles with explicit attention to selection, measurement, structural inequity, informed decision making, screening harms, and follow-up capacity. The resulting synthesis defines a multilevel research architecture linking clinical eligibility, behavioral decisions, accessible service delivery, and longitudinal health outcomes. Research concerning digital and artificial care coordination is presented as a testable future direction. The review is narrative and critical; it reports no original patient-level research, systematic review protocol, or independent meta-analysis.
Keywords: preventive care; screening uptake; health service utilization; health behavior; preventive health services; cancer screening; colorectal cancer screening; cervical cancer screening; HPV self-collection; vaccination uptake; patient reminders; health literacy; Health Belief Model; theory of planned behavior; social cognitive theory; COM-B; health care access; patient navigation; informed choice; medical mistrust; implementation science; health inequity; overdiagnosis; causal inference; pragmatic randomized trial; Artificial Era
Preventive Service Uptake as a Scientific Object
Preventive care, screening, and health service uptake constitute a connected field of inquiry into how people encounter, evaluate, initiate, and sustain health services intended to prevent disease, detect clinically important conditions at an appropriate stage, or reduce future risk. The central outcome is a sequence of interactions between persons and care systems. It may begin with awareness of eligibility, continue through an invitation and a decision, and require scheduling, transport, encounter attendance, test completion, interpretation, follow-up, and recurrence at an evidence-supported interval. These stages create distinct points at which a theoretically beneficial program can fail to reach its intended population. Studies of preventive service uptake therefore examine behavior, clinical organization, and social opportunity simultaneously Andersen (1995) Levesque et al. (2013).
The research object extends beyond the frequency of clinical visits. A recorded attendance may be for acute symptoms, chronic disease management, counseling, vaccination, screening, or an unrelated administrative purpose. Preventive uptake is best measured against a clearly specified intervention, an eligibility rule, a defined observation period, and a denominator of people for whom the service is potentially appropriate. A first vaccine dose differs from series completion; receipt of a mailed screening kit differs from return of an interpretable specimen; a positive screening test differs from completion of diagnostic assessment. Conflating these events obscures the clinical and organizational mechanisms that produce or interrupt continuity Singal et al. (2017) Proctor et al. (2011).
Health psychology approaches this field through beliefs, emotion, anticipated outcomes, perceived control, learning, trust, habit, and decisions under uncertainty. Health services research adds provider availability, cost, appointments, service integration, quality, and institutional performance. Epidemiology asks which populations are eligible, how outcomes are defined, and whether the intervention improves morbidity or mortality. The resulting scientific question is not merely why an individual accepted or refused an invitation; it is how a particular form of care became meaningful, feasible, acceptable, deliverable, and complete under actual circumstances Penchansky and Thomas (1981) Michie et al. (2011).
This monograph uses a critical narrative synthesis of original randomized trials, foundational conceptual studies, systematic reviews, implementation frameworks, and authoritative screening guidance. It is organized around definitions, historical and conceptual development, mechanisms, causal field evidence, measurement, service architecture, distributional equity, and unresolved research problems. The scientific evidence identifies which interventions increase measured uptake in studied settings and clarifies why uptake alone cannot establish a net health benefit. This manuscript reports no original experiment, individual patient data, de novo systematic-search protocol, or independent pooled meta-analysis WHO Regional Office for Europe (2020) Krogsbøll et al. (2019).
Preventive Care, Screening, and the Prevention Continuum
Prevention is commonly discussed as a continuum, but service categories acquire meaning from what is being prevented and for whom. Primary preventive action aims to lower the occurrence of a condition or reduce an established risk; vaccination is a clear example when the relevant vaccine has a favorable evidence base for the target population. Screening seeks to classify apparently asymptomatic people with respect to possible disease or risk in order to offer appropriate confirmation or intervention. Counseling may help people make decisions about tobacco use, activity, nutrition, or other behaviors. Follow-up after an abnormal screen and management of risk factors are components of an organized preventive pathway, even though portions of that pathway are diagnostic or therapeutic rather than screening itself WHO Regional Office for Europe (2020).
Screening is a programmatic offer to a defined population, not simply the performance of a test. The test must have an acceptable balance of accuracy and burden, and an effective pathway must exist from a result to confirmatory assessment and beneficial treatment. Disease natural history matters: detecting an indolent lesion earlier may increase diagnoses without improving the clinical outcomes that matter to patients. Tests can produce false positives, false negatives, incidental findings, unnecessary procedures, and psychological distress. The public health value of a screening program consequently depends on its full chain of effects, its target group, its quality assurance, and its competing uses of limited resources WHO Regional Office for Europe (2020) Welch and Black (2010).
A preventive encounter can contain several distinct decisions: whether to seek a visit, whether to accept a recommended intervention, which available method to use, whether to complete preparation, and whether to return for subsequent stages. Each may be governed by different constraints. A clinician may issue an evidence-based recommendation, while appointment capacity determines whether it can be acted on. A person may favor screening yet postpone it because bowel preparation, childcare, cost, or work absence is difficult. An institution may send a reminder that successfully changes one-stage participation without providing capacity for confirmatory care. Research must preserve these distinctions when defining intervention effects Gupta et al. (2013) Singal et al. (2017).
The unit of analysis can be an individual, household, clinician, clinic, screening program, or population. The choice changes what counts as exposure and outcome. At the individual level, self-report may represent perceived past behavior and future intention. At the program level, administrative records can reveal completed encounters, test processing, and stage transitions. At the population level, participation rates can mask major differences in eligibility, documentation, access, and follow-up. A scientifically useful analysis identifies the population, the offer, the care pathway, the comparison, and the clinical or behavioral endpoint before treating uptake as a success indicator Glasgow et al. (1999) Proctor et al. (2011).
Historical Development of Screening and Health Behavior Research
Modern research on preventive service uptake emerged through several intersecting traditions: public health screening, explanatory models of health behavior, sociology of medical care, and the experimental evaluation of service delivery. Twentieth-century screening programs expanded as tests and treatments became available, while scholars investigated why medically recommended actions were unevenly adopted. Rosenstock's historical account of the Health Belief Model located preventive behavior in perceived vulnerability, seriousness, expected benefit, and obstacles to action; its significance lay in treating acceptance of preventive services as an empirical psychological question rather than a simple reflection of medical instruction Rosenstock (1974).
The Health Belief Model was subsequently applied to many heterogeneous behaviors. Janz and Becker's 1984 review considered 46 studies, including preventive behaviors, responses to illness, and clinic utilization. That breadth made the model influential, but it also exposed the problems of comparing different measures, outcomes, and designs under a single explanatory label. Studies relying on retrospective self-reported beliefs can detect correlations while leaving the timing and causal direction of the belief–action relationship unresolved. Historical influence thus does not convert every dimension of a conceptual model into an independently established cause of screening receipt Janz and Becker (1984).
Health services researchers developed another necessary explanatory level. Penchansky and Thomas's 1981 account specified five dimensions of patient–system fit: availability, accessibility, accommodation, affordability, and acceptability. Andersen's revised behavioral model organized service use through predisposing, enabling, and need-related characteristics, acknowledging the health care system and external environment. These frameworks redirected attention from individual willingness alone to the conditions under which willingness can become observed use. Levesque and colleagues subsequently related the accessibility of services to people's abilities to perceive, seek, reach, pay for, and engage with care Penchansky and Thomas (1981) Andersen (1995) Levesque et al. (2013).
Experimental service-delivery research developed methods for asking whether an invitation, reminder, mailed kit, telephone support, or provider communication causes a change in realized uptake. In colorectal cancer screening, randomized outreach studies separated the clinical method being offered from how the system approached eligible patients and demonstrated that operational design could materially alter completed participation. Longer follow-up then revealed that a strategy producing strong one-time initiation could perform differently when repeated testing and diagnostic follow-up were counted. This progression from belief surveys to pathway-level randomized evidence marked an important methodological maturation Gupta et al. (2013) Green et al. (2013) Singal et al. (2017).
By the 2020s, the research field incorporated pragmatic trials, experimental megastudies, implementation science, population-level evidence reviews, and explicit assessments of screening harms. A 2024 synthesis of randomized vaccination interventions and a 2026 global scoping review of cancer screening participation exemplify a shift toward evaluating interventions across settings rather than treating one clinic's association as universally applicable. The mature field must integrate psychological explanation with opportunities for care, longitudinal service completion, and the net clinical value of the underlying intervention Liu et al. (2024) Kigongo et al. (2026).
The Evidence Threshold for an Appropriate Preventive Service
Scientific evaluation must begin before a participation rate is measured. A screening program requires an adequately specified target population, a condition with meaningful burden, an acceptable test, a known downstream diagnostic and treatment pathway, and evidence that offering the program yields benefits which justify its harms and opportunity costs. WHO's screening guidance describes these requirements as principles of program design, assessment, and quality assurance. In this conception, increasing participation in an ineffective or poorly targeted service may raise costs and burdens while failing to improve health WHO Regional Office for Europe (2020).
The 2019 Cochrane review of general health checks offers a cautionary case. Across 17 randomized trials, 15 reporting outcome data included 251,891 participants. For total mortality, the pooled estimate from 11 trials was a risk ratio of 1.00 with a 95 percent confidence interval from 0.97 to 1.03. These results pertain to multidisease general checks in adults unselected for disease or risk factors; they do not prove that targeted evidence-based screening or a particular vaccine lacks benefit. They demonstrate that a high level of preventive activity and the detection of additional abnormalities do not themselves establish improved population outcomes Krogsbøll et al. (2019).
Overdiagnosis makes the difference between detection and benefit especially important. Welch and Black explained overdiagnosis as the identification of a condition that would not have produced symptoms or death during a person's lifetime. Improved detection sensitivity can therefore enlarge disease counts and treatment exposure without proportional clinical gain. Other harms include unnecessary biopsies, anxiety, exposure to procedural complications, and false reassurance after negative tests. Appropriate uptake metrics belong beside measures of harms, clinically meaningful endpoints, preferences, and follow-up capacity Welch and Black (2010) WHO Regional Office for Europe (2020).
Recommendations are also contingent on population characteristics and time. A recommendation issued for a particular age group, risk profile, and health system may change as trial evidence, test technology, prevalence, or treatment improves. The 2021 US Preventive Services Task Force colorectal screening recommendation illustrates population-specific eligibility and the distinction between recommended tests and associated follow-up, but a country-specific guideline is evidence to interpret rather than a universal rule. A monograph about service uptake should therefore identify the date and jurisdiction of each recommendation and keep psychological findings analytically distinct from individual clinical advice US Preventive Services Task Force (2021) WHO Regional Office for Europe (2020).
The Prevention Pathway as the Unit of Analysis
A pathway model represents preventive care as a series of linked states: potential eligibility, valid identification, offer or invitation, awareness, appraisal, decision, scheduling, access, encounter or specimen completion, result communication, confirmatory action, and subsequent indicated care. Longitudinal recurrence may follow for periodic screening or multidose vaccination. The model is analytic: actual pathways may branch, repeat, or terminate appropriately when a person makes an informed decision not to proceed. It makes precise the difference between demand generation, service delivery, and clinical completion Levesque et al. (2013) Singal et al. (2017).
Each transition has a numerator, denominator, time interval, and possible source of missingness. An invitation reach rate uses everyone for whom outreach was attempted as its denominator; a returned-test rate may use people mailed a kit; diagnostic completion following a positive test uses those with a result requiring follow-up. These measures answer different questions. A system that counts only patients attending a clinic excludes people whose inability to obtain appointments is central to the research problem. A program that counts dispatches as successful outreach obscures whether communication reached, was understood by, or was actionable for the intended person Proctor et al. (2011) Glasgow et al. (1999).
The model also distinguishes voluntary nonparticipation from constrained nonparticipation. Declining a low-value or preference-sensitive screening intervention after receiving accessible information can represent competent decision making. Missing an evidence-based appointment because transport, interpretation, money, or clinic hours are unavailable is a different event. Research instruments that code both as nonadherence collapse ethical choice and structural exclusion. A better measurement strategy combines choice quality, opportunity indicators, participation, and completion so that equity goals remain compatible with informed decisions O'Connor (1995) Penchansky and Thomas (1981).
This monograph therefore evaluates interventions at their actual point of action. A message may alter salience, a clinician's recommendation may alter trust or perceived norm, a prepaid mailed kit may reduce effort, navigation may enable an appointment, and a registry may trigger timely follow-up. The causal hypotheses differ, and their effects should be assessed over intervals long enough to observe the relevant clinical stage. Evidence from one-time outreach and three-year screening process completion demonstrates why these distinctions cannot be left implicit Gupta et al. (2013) Singal et al. (2017).
Risk Appraisal, Expected Benefit, and Perceived Barriers
A person's response to a preventive offer is shaped by interpretation of susceptibility, severity, intervention benefit, costs, and likely consequences. These variables are often organized through the Health Belief Model. The model is useful because a clinically eligible person may regard a disease as distant, doubt the value of a test, expect embarrassment, or anticipate burdens from a positive result. The content of such beliefs matters for explanation, but surveys can measure them imprecisely, and perceived risk cannot be treated as an independent lever that invariably causes participation Rosenstock (1974) Janz and Becker (1984).
Risk beliefs also have multiple temporal and conditional forms. A person can accurately estimate population risk yet misjudge personal risk; an individual may perceive screening as reducing the chance of disease rather than changing the timing of detection; and someone who has already been screened may retrospectively report higher perceived benefit as a rationalization of prior action. Cross-sectional associations between risk perception and uptake should therefore be interpreted in view of baseline risk, disease knowledge, prior experiences, and chronological ordering. Longitudinal measurements before and after an invitation help distinguish predictive beliefs from beliefs formed through participation Janz and Becker (1984) O'Connor (1995).
Perceived barriers form a heterogeneous construct. Embarrassment, fear of pain, anticipated stigma, uncertainty about test preparation, expected financial burden, limited appointments, and lack of transportation do not constitute a single psychological mechanism. Some refer to beliefs that could be corrected with accurate information; others describe material conditions that remain after beliefs change. The most useful analytic distinction is whether a barrier can be reduced through information, interpersonal support, task redesign, or system-level resource change. A theory of uptake becomes more powerful when it specifies how a named barrier alters an observable pathway transition Penchansky and Thomas (1981) Levesque et al. (2013).
Benefit communication requires the same precision. A message about preventing disease differs from a message about detecting an existing condition, and a relative risk statistic can sound persuasive while concealing a small absolute benefit. Informed decisions require understandable presentation of possible benefits, false-positive results, downstream procedures, overdiagnosis, and alternatives where relevant. Positive beliefs about screening are not intrinsically more accurate than negative beliefs; they must be evaluated against the best available evidence for the intervention and population. This is a central interface between health psychology, clinical epidemiology, and decision science WHO Regional Office for Europe (2020) Welch and Black (2010).
The empirical question is how a particular appraisal affects a particular act under a particular opportunity structure. An invitation might raise perceived urgency among people who can obtain testing while producing little change among people whose workplaces prohibit time off. Conversely, a mailed kit may dramatically change observed behavior with little evidence that underlying disease-risk beliefs changed. Interventions that alter opportunity provide a natural test of the limits of purely cognitive explanation Gupta et al. (2013) Michie et al. (2011).
Intentions, Norms, Self-Efficacy, and Action Control
The Theory of Planned Behavior relates intention to attitudes toward a behavior, perceived social norms, and perceived behavioral control. Applied to preventive services, it predicts that expectations about outcomes, perceived approval by important others, and confidence in arranging care may influence a person's intention to attend. Intention is an intermediate construct: the endpoint for public health is often confirmed participation and appropriate completion. Intention–behavior discrepancies become particularly important when people must navigate several steps, each with practical costs Ajzen (1991).
Social cognitive theory emphasizes self-efficacy, observational learning, outcome expectations, and self-regulation. For preventive care, self-efficacy may involve confidence in booking an appointment, asking questions, understanding test instructions, obtaining transportation, or completing self-collection. These capabilities are task-specific. A person might readily request a vaccination while feeling unable to manage preparation for colonoscopy. Programs should therefore measure confidence and effective behavior at the actual task level instead of treating a general self-efficacy score as a proxy for all preventive actions Bandura (2004).
The COM-B framework distinguishes capability, opportunity, and motivation as interacting conditions of behavior. Psychological capability can include knowledge and comprehension; physical capability may include abilities needed for specimen collection or travel; social and physical opportunity include supportive environments and available services; motivation includes deliberative beliefs alongside habits and automatic responses. This model offers a diagnostic framework for intervention design. If the limiting factor is limited clinic capacity, a persuasive message is unlikely to deliver a complete care episode; if the obstacle is unfamiliar instructions, a clearer explanation might be consequential Michie et al. (2011).
Preventive decisions are time distributed. A reminder delivered immediately before a visit may reduce forgetting, but it cannot retrospectively restore weeks of inaccessible appointments. Forming an intention while reading an invitation is different from executing a sequence of preparatory actions over several days. Recurrent services impose the additional burden of maintaining a schedule despite changes in work, residence, insurance, and health status. Studying the interval between invitation and completion makes the intention–action gap observable as a series of delays, missed transitions, and successful recoveries Green et al. (2013) Singal et al. (2017).
These models offer complementary mechanisms rather than interchangeable labels. Health Belief Model constructs emphasize disease and intervention appraisal; planned behavior emphasizes intention and perceived norm; social cognitive theory addresses efficacy and behavioral regulation; COM-B organizes intervention-relevant capacities and opportunities. Empirical comparison demands measures that discriminate constructs, baseline assessment before participation, and intervention designs that manipulate an identified determinant. Using several theories to redescribe the same observed correlation adds little explanatory value unless it yields different predictions that can be tested Janz and Becker (1984) Ajzen (1991) Bandura (2004) Michie et al. (2011).
Affect, Medical Experiences, and Trust in Care
Preventive encounters carry anticipatory emotions. Fear of diagnosis, discomfort, embarrassment, anxiety about clinical procedures, and worry about possible results can change how a person attends to information and evaluates an offer. Emotional experiences after earlier care may persist into later decisions. Behavioral measurement should distinguish transient anticipatory affect from enduring avoidance patterns, previous trauma, and simply rational concern about the harms of an intervention. The meaning of fear is conditional: fear may prompt some people to seek timely assessment while prompting others to disengage O'Connor (1995) Welch and Black (2010).
Trust operates at several levels. Interpersonal trust concerns a particular clinician's competence, honesty, and respect. Institutional trust concerns whether a clinic reliably protects privacy, provides fair treatment, communicates results, and can complete promised care. Public trust concerns health authorities and the basis on which recommendations are made. These forms of trust can diverge. A person might trust a familiar nurse while distrusting a health care system that previously failed to provide follow-up. Evidence on service access therefore cannot be reduced to one unmeasured attitude called mistrust Levesque et al. (2013) Andersen (1995).
Communication style changes both the informational and relational environment. A direct, routine vaccine announcement can make an eligible vaccination appear part of ordinary preventive practice; participatory conversation may be essential when a patient has substantive concerns or needs a preference-sensitive decision. Research comparing communication approaches should not assume that one script fits all clinical choices. Vaccination is not identical to screening for a condition in which net benefit varies strongly by age, life expectancy, risk, and preference. The clinical appropriateness of the recommendation sets the ethical boundary for communication interventions Brewer, Hall, et al. (2017) WHO Regional Office for Europe (2020).
Cultural and linguistic context influences which explanation is credible, accessible, and respectful. The same information may be encountered through clinicians, family, peers, media, community organizations, or digital services. Experiences of discrimination and inconsistent service quality can rationally inform expectations about whether care will be safe and responsive. Research should specify which institution, historical setting, social group, and service are involved before extrapolating findings about trust. Translation, representation, and continuity with trusted practitioners may change both comprehension and feasibility Levesque et al. (2013) Berkman et al. (2011).
Trust should be studied through observable institutional behavior as well as attitudes. Measures can include response times, successful disclosure of test results, language-concordant communication, resolution of concerns, ability to change clinicians, consistency between promised and delivered services, and the treatment of privacy. Such measures permit researchers to ask whether trust follows sustained care quality or independently predicts later service completion. A research design that intervenes on the reliability of follow-up may provide stronger causal evidence than a questionnaire asking whether people trust medicine in general Proctor et al. (2011) Glasgow et al. (1999).
Health Literacy, Numerical Understanding, and Decisional Quality
Health literacy includes people's capacities to access, understand, appraise, and use health information in real contexts. In preventive care, an individual must often interpret eligibility letters, interval recommendations, instructions, consent materials, probability statements, and abnormal test results. Literacy is relational to the demands imposed by a communication system. Complexity of wording, fragmented portals, unexplained medical terminology, and inaccessible language services can transform a theoretically simple offer into a sequence of comprehension barriers. Berkman and colleagues' systematic review documents associations between limited health literacy and diverse adverse health-care outcomes, while calling attention to the heterogeneity of instruments and outcomes Berkman et al. (2011).
Numerical comprehension deserves explicit attention because screening results express probabilities across several stages. Test sensitivity and specificity do not directly tell an individual the positive predictive value in a particular risk population. A test can detect most disease cases yet yield many false-positive results where underlying prevalence is low. A positive result is usually an indication for further evaluation, not a diagnosis by itself. Decision communication can present absolute frequencies, time horizons, plausible harms, and the meaning of subsequent tests in a way that permits people to understand the stakes of the decision WHO Regional Office for Europe (2020) Welch and Black (2010).
The Decisional Conflict Scale developed and validated by O'Connor is an example of an instrument designed to assess uncertainty, factors contributing to that uncertainty, and perceived effective decision making. Its historical validation included choices about influenza vaccination and breast cancer screening. The instrument clarifies that feeling uncertain is not synonymous with defective reasoning: uncertainty can arise when meaningful benefits and harms must be weighed. A good decision-support process seeks adequate information, values clarity, and an informed choice rather than maximizing stated certainty or generating a predetermined decision O'Connor (1995).
Health literacy interventions must be assessed beyond reading-level changes. The important outcomes include comprehension of the actual recommendation, recall of the action needed, accurate expectation of possible test results, ability to navigate follow-up, and alignment between a decision and the person's informed preferences. A simplified letter may improve reading comprehension without overcoming cost or transportation barriers. Conversely, at-home testing may lower the functional literacy and logistical demands of a screening pathway by moving complex tasks out of the clinic. These different mechanisms are amenable to randomized evaluation Berkman et al. (2011) Pretsch et al. (2023).
For preference-sensitive services, quality of informed choice should accompany uptake measurement as an ethical endpoint. For services with strong benefit in a clearly eligible group, programs still owe clear explanations of benefits, burdens, alternatives, and relevant uncertainty. Research should distinguish a person who has declined after understanding the offer from someone who never received comprehensible information. An approach that measures only completion risks wrongly treating ethically appropriate refusal as failure and informational exclusion as individual reluctance O'Connor (1995) WHO Regional Office for Europe (2020).
Opportunity, Access, and the Realization of Care
A person can have knowledge, confidence, and intention while lacking a practicable route to services. Penchansky and Thomas's five dimensions of access distinguish the supply of services, geographic reachability, fit between operating arrangements and patient needs, affordability, and sociocultural acceptability. These dimensions can interact. A clinic may be nearby yet offer appointments only during working hours; a test may be covered yet incur transport or caregiving expenses; a service may have staff and equipment but lack language access or confidentiality protections perceived as essential Penchansky and Thomas (1981).
Andersen's behavioral model situates realized service use among predisposing characteristics, enabling resources, and need. Its implication for prevention research is that an observed pattern of low attendance may have several different determinants: variation in eligibility and health status, uneven service availability, unequal enabling resources, or perceptions shaped by prior experience. Statistical adjustment for age and diagnosis does not remove a service system's unequal distribution of time, cost, and access. Studies should identify the explanatory level of each variable before interpreting regression coefficients as individual preferences Andersen (1995).
Levesque, Harris, and Russell recast access as an interface between the dimensions of services and a person's abilities to perceive a need, seek care, reach a provider, pay, and engage. This framework is particularly useful for preventive services because apparent absence of illness can weaken the perceived need to seek care, while service systems rely on people to navigate appointment logistics. The capacity to engage also becomes crucial after an abnormal screening result. Access is thus a dynamic relation rather than a single distance, insurance category, or yes-or-no availability variable Levesque et al. (2013).
Opportunity constraints often shape the apparent effectiveness of psychological interventions. Reminder texts assume a working phone number, permission to receive messages, adequate literacy, and an accessible booking system. Mail-based programs assume a reliable postal address and the ability to return specimens privately. Digital self-scheduling assumes connectivity, appropriate devices, and platform accessibility. Trials that report average effectiveness should describe the groups excluded by these assumptions and assess whether improved mean uptake coincides with widening gaps among people who cannot use the intervention Glasgow et al. (1999) Kigongo et al. (2026).
The practical consequence is an intervention hierarchy grounded in diagnosis of the failure point. Where people are never identified as eligible, registry improvement may matter most; where appointments are scarce, capacity expansion is necessary; where preparation is burdensome, alternative evidence-based modalities or navigation may help; where the return stage fails, tracking and follow-up systems become essential. Persuasion may be effective for a genuine motivational barrier, but opportunity and operational continuity are often the more direct and ethically defensible targets Michie et al. (2011) Levesque et al. (2013).
Randomized Outreach for Colorectal Cancer Screening
Colorectal cancer screening outreach provides one of the clearest experimental literatures on preventive service uptake. Programs can identify eligible patients through clinical records, send an invitation, supply a stool-based test, offer colonoscopy scheduling, and arrange follow-up after an abnormal result. The behavioral mechanism is partly reduced effort: the offer arrives without waiting for a routine visit, and testing can be initiated through a convenient channel. Yet the methods differ in preparation requirements, frequency, diagnostic follow-up, invasiveness, and the patient's perceived burden. These attributes shape both initial behavior and longer-term process completion Gupta et al. (2013) Singal et al. (2017).
In a randomized clinical trial in an underserved population, Gupta and colleagues compared mailed fecal immunochemical test outreach, colonoscopy outreach, and usual visit-based care. Screening participation within a year was 40.7 percent in the fecal immunochemical test outreach arm, 24.6 percent in the colonoscopy outreach arm, and 12.1 percent with usual care. The trial supports a causal effect of the assigned outreach package on the defined uptake outcome in the studied health system. It does not isolate the content of a single letter from the effects of test availability, telephone assistance, institutional capacity, and the particular comparison condition Gupta et al. (2013).
A crucial limitation appears after the first positive screening result. The same trial reported that 11 of 60 patients with an abnormal fecal immunochemical test did not complete colonoscopy within the specified follow-up, showing that increased initial testing can coexist with unfinished diagnostic pathways. This is a consequential distinction: a screening program creates clinical responsibility for interpreting results and ensuring access to further evaluation. A high kit-return rate can conceal a significant loss of effectiveness if abnormal results are not acted upon. Preventive uptake studies therefore need multistage outcomes rather than reporting test receipt alone Gupta et al. (2013) WHO Regional Office for Europe (2020).
Green and colleagues tested an automated approach with stepped increases in support for colorectal cancer screening. The design illustrates how a registry, reminders, and assistance can be combined to reach patients who might not respond to a single invitation. Its intervention logic concerns delivery at population scale: automated contact handles a broad cohort, while additional resources are focused on those who remain unscreened. An evaluation should examine both effectiveness and the costs or labor required for each additional completed episode, because a scalable system may perform differently from a tightly supervised efficacy trial Green et al. (2013) Glasgow et al. (1999).
Together these experiments suggest that the offer's delivery channel, test logistics, and support structure are integral components of participation. They do not establish one universally superior screening method or invitation. The observed effect depends on local access, test availability, prior screening history, and the outcome's observation period. The strongest generalizable conclusion is that organized outreach can outperform reliance on opportunistic clinical visits when eligible people encounter barriers to initiating screening, while appropriate confirmation and recurrence require separate infrastructure Gupta et al. (2013) Green et al. (2013) Singal et al. (2017).
From First Test to Three-Year Screening Process Completion
The distinction between initial uptake and sustained completion is empirically testable. In a later pragmatic randomized trial, Singal and colleagues followed 5,999 adults receiving care in a safety-net system and compared fecal immunochemical test outreach, colonoscopy outreach, and usual care over three years. The primary measure was completion of the screening process, including required repeat testing and diagnostic evaluation, rather than participation in any single test. The study therefore measured the continuity of preventive service delivery more directly than a one-year initiation endpoint Singal et al. (2017).
Screening process completion occurred in 38.4 percent of those assigned colonoscopy outreach, 28.0 percent of those assigned mailed fecal immunochemical test outreach, and 10.7 percent of those receiving usual care. These contrasts differ from the relative ranking of the one-year uptake rates observed in the earlier Gupta study. The comparison should not be interpreted as contradiction: the trials used different populations, periods, outcome definitions, and operational pathways. For a repeating stool-test strategy, each screening round and follow-up after a positive result is part of remaining up to date, whereas a completed colonoscopy may satisfy the period-specific definition without annual stool testing Gupta et al. (2013) Singal et al. (2017).
This study exposes a common measurement error in behavior-change research: assigning a label such as screening success to outcomes that differ in clinical completeness. A mailed kit can be returned once and generate an impressive short-term uptake statistic while the longitudinal program experiences attrition over subsequent rounds. Conversely, a method requiring greater preparation at initiation might lead to a different pattern of long-term adherence after completion. A proper evaluation should specify the intervention's intended interval and compare clinically equivalent states, where possible, rather than treating all evidence of participation as the same endpoint Singal et al. (2017) WHO Regional Office for Europe (2020).
The findings also illustrate why prevention is a service system property. Patients require reminders for repeated tests, timely communication after results, clear preparation instructions, access to specialist appointments, and a mechanism for resolving delays. Each transition introduces potential differential loss for patients with unstable housing, changing insurance, variable schedules, or limited transport. Without stage-specific denominators, a program may overestimate success and underestimate the concentration of follow-up failures among particular groups Levesque et al. (2013) Singal et al. (2017).
The broader methodological lesson extends to vaccination series, cervical screening intervals, and periodic preventive counseling. Researchers should distinguish willingness, first action, completion of the indicated series, long-term maintenance, and downstream benefit. A behavioral intervention proven to increase one endpoint has earned that specific claim; claims about improved mortality, sustained protection, or reduced inequity require additional designs and outcomes. This conclusion establishes a principled boundary for interpreting apparently impressive uptake effects Krogsbøll et al. (2019) Proctor et al. (2011).
Cervical Screening, Self-Collection, and Reconfigured Opportunity
Cervical cancer screening highlights a different delivery problem: participation may be shaped by privacy, discomfort, cultural context, work constraints, travel, and the necessity of an in-person examination. Human papillomavirus self-collection permits a specimen to be obtained outside a conventional clinic encounter under the conditions for which the method is clinically validated and authorized. The relevant psychological mechanism may include greater perceived autonomy or reduced embarrassment, while the service mechanism includes eliminating an appointment for the initial specimen collection. These hypotheses must be tested together, because the resulting participation improvement cannot be assigned to an attitude change alone Pretsch et al. (2023).
The My Body, My Test-3 trial by Pretsch and colleagues compared mailed human papillomavirus self-collection kits combined with appointment-scheduling assistance against scheduling assistance alone among underscreened women from low-income backgrounds in North Carolina. The primary analysis included 665 participants after the protocol's post-randomization exclusions. Screening uptake occurred in 317 of 438 participants in the intervention group, approximately 72 percent, and 85 of 227 controls, approximately 37 percent, yielding a reported risk ratio of 1.93 with a 95 percent confidence interval from 1.62 to 2.31. This is direct randomized evidence that changing the service offer can change realized screening uptake in a population with pronounced access constraints Pretsch et al. (2023).
Interpretation requires preserving the trial's specifics. Participants had volunteered, met eligibility criteria, and received structured program contact. The intervention bundled provision of self-collection kits with scheduling assistance; it did not isolate the effect of kit packaging, privacy, or individual risk perception. Returned self-samples were included in the trial outcome under its operational definition, while a positive test still calls for appropriate clinical follow-up. The findings cannot be generalized automatically to every screening technology, anatomical site, country, regulatory framework, or population Pretsch et al. (2023) WHO Regional Office for Europe (2020).
The study illustrates an important equity mechanism: when standard clinic-based care carries a disproportionate time, financial, social, or privacy burden, a validated home-based option can alter the actual choice set. An intervention that offers more practical options may improve uptake even when the target population's knowledge is unchanged. It can also create new exclusion risks if postal delivery, private space, technology, literacy, or return shipping are unavailable. Implementation research should therefore compare not only average test completion but also who successfully receives a kit, returns a valid specimen, obtains a result, and completes any indicated follow-up Levesque et al. (2013) Pretsch et al. (2023).
This case also clarifies why patient choice and public health effectiveness should be evaluated jointly. Some people prefer clinician-collected testing; others prefer self-collection. Meaningful access consists in safe and appropriately recommended alternatives that can be used under real circumstances. The scientific focus is the fit between delivery models and lived conditions, accompanied by quality assurance across the entire screening pathway Penchansky and Thomas (1981) WHO Regional Office for Europe (2020).
Breast Screening, Overdiagnosis, and the Limits of Uptake Maximization
Breast screening illustrates why the desirability of participation cannot be inferred from an uptake percentage alone. The balance of screening benefits and harms varies by age, background risk, screening interval, test technology, and diagnostic and treatment pathways. Early detection can reduce harmful disease outcomes in particular circumstances, but screening can also produce false-positive findings, unnecessary assessment, and overdiagnosis. Counseling and invitations should communicate those possibilities with the degree of certainty justified by the applicable evidence. Treating maximal uptake as an ethical requirement would erase the distinction between informed participation and promotion at any cost WHO Regional Office for Europe (2020) Welch and Black (2010).
Overdiagnosis is a counterfactual concept: it concerns disease detected during screening that would not have progressed to cause symptoms or death in that person's lifetime. It cannot ordinarily be identified for an individual patient simply from one pathology result. Researchers use population comparisons, follow-up periods, and modeling assumptions to estimate its extent, each with limitations. This makes overdiagnosis unlike a false-positive test result, where later assessment may establish absence of the target condition. A careful monograph distinguishes the two mechanisms and their implications for informed decision making Welch and Black (2010).
Psychological outcomes should also be measured with scientific discrimination. Short-term anxiety after a recalled mammogram, distress associated with a false-positive result, and regret following an unnecessary procedure differ in duration, clinical significance, and causal origin. Likewise, a person may experience reassurance after a negative test yet misunderstand residual risk. Studies relying on a single satisfaction question cannot capture these outcome dimensions. Measurement should align with the stage of screening, the result received, and the individual preference context O'Connor (1995) WHO Regional Office for Europe (2020).
The ethical target of a screening program is equitable access to a beneficial and appropriately selected intervention together with informed agency, quality assurance, and reliable follow-up. Where evidence for net benefit is strong, systems have a responsibility to reduce avoidable logistical exclusion. Where trade-offs are preference-sensitive, systems have a responsibility to support well-understood choices, including declining. Both cases require accurate explanations and documentation of what the service can and cannot accomplish WHO Regional Office for Europe (2020) Krogsbøll et al. (2019).
Vaccination as a Preventive Service and Behavioral Pathway
Vaccination uptake involves clinical eligibility, vaccine availability, an offer or recommendation, informed acceptance, administration, and, where relevant, completion of a recommended series and later doses. These stages parallel screening uptake while differing in their clinical causal chain: a vaccine aims to generate protection against a disease or severe outcome, whereas a screening test identifies people for further assessment or intervention. The population value of vaccination also depends on epidemiological circumstances, product effectiveness, safety, and coverage patterns. Psychological theories explain how people respond to the service offer, while immunological and epidemiological evidence establishes the intervention's clinical value Brewer, Chapman, et al. (2017) Liu et al. (2024).
Vaccination intention is influenced by perceptions of disease risk, confidence in vaccine safety and effectiveness, perceived norms, anticipated regret, provider recommendations, and practical opportunity. However, intention is only one determinant of administered doses. Appointment convenience, vaccine stocking, language access, reminder timing, transportation, and consent procedures can determine whether an otherwise willing person becomes vaccinated. This distinction prevents researchers from describing every low-uptake population as hesitant when a service was inaccessible or never effectively offered Brewer, Chapman, et al. (2017) Michie et al. (2011).
Psychological science also distinguishes misinformation, uncertainty, legitimate questions, and different grounds for nonparticipation. The same response on an attitude questionnaire may represent conflicting sources, previous adverse clinical experiences, insufficient opportunity to obtain professional advice, or a deeply held belief. A well-designed study specifies these mechanisms and examines whether an intervention changes factual understanding, intention, or actual immunization. Reliance on a broad hesitancy score without local context can conceal the practical target for intervention Brewer, Chapman, et al. (2017) Levesque et al. (2013).
Vaccination programs frequently operate through systems of repeated contact: schools, primary care, pharmacies, community clinics, occupational health, and public campaigns. These settings differ in eligibility rules, trust relationships, opportunity costs, and data infrastructure. A message successful at the point of a scheduled clinical visit may not have the same effect in a community with few reachable facilities. The field therefore requires comparative trials and implementation assessment of site, target group, intervention components, and durability rather than one general estimate of the effect of persuasion Milkman et al. (2021) Liu et al. (2024).
Provider Communication and the Announcements Trial
Clinician recommendation is a critical interpersonal moment because a recommendation can communicate both the content of clinical guidance and the practitioner's expectation that preventive care is an ordinary element of practice. Yet recommendation quality depends on accuracy, patient context, and the opportunity for questions. Studies of communication should measure actual doses, timing, and clinical appropriateness, while also considering whether communication preserves patient autonomy and trust Brewer, Chapman, et al. (2017).
Brewer and colleagues conducted a randomized trial comparing practice training in announcements with a more conversational communication approach for human papillomavirus vaccination. Announcements presented vaccination as a routine recommendation made in the context of a clinical encounter. The trial found a greater increase in vaccination initiation in clinics trained in announcements than in control clinics, while training in conversations did not produce a comparable increment beyond background change in the reported analysis. This trial tests a specific communication intervention, age group, clinical setting, and outcome; its design is more informative for causal inference than retrospective reports of which communication styles vaccinated patients remember Brewer, Hall, et al. (2017).
The reported announcement advantage should not be converted into a general prescription to suppress questions. A vaccine recommendation must remain evidence-based and responsive to contraindications, individual concerns, and local clinical standards. The study's primary behavior endpoint was initiation in a pediatric practice context, not a universal measure of informed decisional quality or long-term completion of every vaccine schedule. A communication intervention can be effective for an indicated, routine service while other health decisions appropriately demand extended deliberation Brewer, Hall, et al. (2017) O'Connor (1995).
From an implementation perspective, the distinction matters because provider communication is trainable yet embedded in workflow. Clinicians require appointment time, documentation systems, appropriate supplies, and escalation paths for questions. Variation in staff roles, patient populations, and appointment length may modify what can be implemented faithfully. A program evaluation should assess training adoption, fidelity, patient experience, and clinical uptake, recognizing that these are related but distinct outcomes Proctor et al. (2011) Glasgow et al. (1999).
Digital Reminders and the Vaccination Megastudy
Reminder systems act on different aspects of action control than conventional educational campaigns. A text message close to an existing clinical appointment may make a preventive task salient when the opportunity to complete it is immediate. Short messages can also simplify the next step by specifying that a vaccine is available during a scheduled visit. The mechanism may involve reduced forgetting, planning effort, or perceived ownership of an appointment rather than a substantial shift in beliefs about disease risk Milkman et al. (2021).
Milkman and colleagues reported a large field experiment involving 47,306 patients and 19 different text-based nudges designed to encourage influenza vaccination at an upcoming physician appointment. The study found that messages increased vaccination relative to control communication, with particular success for reminders indicating that the vaccine had been reserved for the patient. Its experimental comparison permits statements about the effects of assigned message variants in that participating health-system context. It does not establish that identical wording will succeed across vaccine types, countries, or populations with different access conditions Milkman et al. (2021).
The megastudy design provides an important methodological contribution: many intervention variants were examined within a coordinated experimental infrastructure and against a common outcome. Such designs can compare message strategies with greater statistical precision than separate small trials, but individual effects still depend on communication reach, baseline vaccination rates, clinical opportunities, and local expectations. A message expected from a trusted clinic may differ from an unsolicited message that appears suspicious or intrusive. Implementation therefore needs privacy and communication governance as well as behavioral design Milkman et al. (2021) Levesque et al. (2013).
Digital systems also create new forms of selection. Patients without stable phone numbers, consent to receive messages, accessible devices, adequate literacy, or language-concordant communication may be missed. An analysis restricted to successful message recipients may overestimate population reach by excluding the individuals most difficult to contact. Intention-to-treat designs that include all assigned eligible patients, together with delivery and engagement indicators, offer a stronger basis for assessing real-world impact Glasgow et al. (1999) Proctor et al. (2011).
The scientific comparison should report at least the assigned intervention, reached participants, administered dose, follow-up interval, and relevant safety or privacy outcomes. An increase in link clicks or appointment intentions is not equivalent to vaccine administration. Studies of reminders must also distinguish uptake of the targeted vaccine from substitutions or unrelated health-service activity and avoid inferring durable adherence from one appointment. These requirements are the same outcome-specific discipline applied to screening outreach Milkman et al. (2021) Singal et al. (2017).
Systematic Evidence on Increasing Vaccination Uptake
Single vaccination trials establish local causal effects; systematic reviews ask whether their findings recur and which intervention families have the strongest evidence across populations. Brewer and colleagues' psychological synthesis organized intervention approaches around thoughts and feelings, social processes, and direct facilitation of action. Its central contribution is to connect established psychological mechanisms with intervention choices, while recognizing that changing an attitude does not necessarily change behavior where opportunity is limited Brewer, Chapman, et al. (2017).
Liu and colleagues' 2024 meta-analysis analyzed 88 eligible randomized controlled trials encompassing 1,628,768 participants across 17 countries. This scale permits comparison of vaccination intervention classes across diverse settings, although pooled estimates remain sensitive to intervention definitions, outcomes, follow-up periods, risk of bias, and between-study differences. A meta-analysis of uptake effects does not by itself estimate long-term clinical outcomes or the performance of every intervention in a specific local health system Liu et al. (2024).
The most useful synthesis distinguishes whether an intervention primarily supplies information, changes social expectations, facilitates the task directly, or reorganizes the delivery system. A reminder can create an immediate behavioral opportunity; a clinician recommendation can clarify a norm and the clinical rationale; improved access may enable willing people to complete the action. A multi-component intervention may combine these operations, making the aggregate treatment effect easier to establish than the relative importance of each component Brewer, Chapman, et al. (2017) Liu et al. (2024).
Evidence quality must be assessed within each category. Trials that randomize patients can estimate message effects when access is relatively uniform; cluster-randomized practice interventions must account for correlation within clinics; observational before-and-after campaigns are especially vulnerable to seasonality and contemporaneous changes in vaccine availability. Differences in follow-up and reported endpoints can produce misleading comparisons, even when all studies use the phrase vaccination uptake. A scientifically defensible synthesis keeps the counterfactual and endpoint visible Brewer, Hall, et al. (2017) Milkman et al. (2021) Liu et al. (2024).
Cross-national generalization requires attention to eligibility schedules, health financing, vaccine availability, disease burden, political context, and the legal organization of care. The presence of 17 countries in a meta-analysis broadens evidence but does not imply representation of all health systems or marginalized communities. Future trials should report intervention reach, delivery costs, differential effects, and sustained completion to identify which results can be transported beyond the studied setting Liu et al. (2024) Glasgow et al. (1999).
Evidence-Based Counseling, Preventive Visits, and Clinical Continuity
Preventive counseling often aims to change a health behavior rather than deliver a single test or dose. Its study requires separate measurement of whether counseling was offered, delivered with sufficient fidelity, understood, accepted, and followed by a change in behavior or clinical risk. A billed visit can be recorded even when the evidence-based counseling component was abbreviated or omitted; a counseling conversation can occur without a billing code. Uptake of the encounter and effectiveness of the counseling intervention are therefore different constructs Bandura (2004) Proctor et al. (2011).
Behavioral counseling services are also preference-, readiness-, and capability-sensitive. A person may welcome discussion of smoking cessation but lack access to affordable cessation support, or may receive lifestyle guidance that is impracticable under current housing, work, or disability conditions. Effective intervention design begins with the behavior's opportunities and capabilities and connects brief advice to available follow-up resources. The COM-B approach offers a way to identify these requirements without assuming that knowledge is the only missing ingredient Michie et al. (2011) Levesque et al. (2013).
Routine preventive visits can provide a platform for appropriate screening, vaccination, and counseling, particularly when longitudinal relationships permit continuity and coordinated follow-up. However, the evidence on general multiphasic health checks warns against treating an undifferentiated annual examination as inherently beneficial for every adult. A well-designed evaluation separates targeted interventions with favorable evidence from bundled low-value procedures and considers clinical outcomes, resources, and harms Krogsbøll et al. (2019) WHO Regional Office for Europe (2020).
The public health challenge is thus to translate intervention-specific evidence into reliable pathways. Clinical guidelines identify candidates for particular services; health psychology clarifies the decisions and experiences surrounding an offer; service design determines whether people can actually receive, complete, and benefit from appropriate care. Good research observes these stages explicitly, especially when care needs to recur or be coordinated across clinicians Andersen (1995) Proctor et al. (2011).
Measuring Uptake with Valid Denominators and Time Horizons
Preventive uptake is often represented as the percentage of eligible people who complete a service. That calculation is meaningful only if eligibility, action, observation window, and data capture are specified consistently. Denominators can include all persons living in a catchment area, patients attributed to a clinic, persons invited, those successfully contacted, or those who attended another appointment. The same number of completed tests yields different participation rates under these definitions. Analyses must identify whether the denominator reflects the eligible population or a selected subset already connected to services Glasgow et al. (1999) Proctor et al. (2011).
Time windows matter because health behavior may be delayed but eventually completed, or initiated once without necessary repetition. An outreach invitation measured over 30 days is not equivalent to screening completion over a year; three-year colorectal screening process completion encompasses repeat tests and follow-up that a first-year initiation measure omits. Clinical guidelines also differ in recommended interval, so counting one completed test as success throughout a fixed study period may be inappropriate across screening modalities. Researchers should justify how their endpoint corresponds to the service's evidence-based pathway Gupta et al. (2013) Singal et al. (2017).
Electronic records offer substantial advantages over retrospective self-report: dates, documented tests, vaccine administration, ordering and processing can sometimes be verified. Yet records also miss care received outside a network, contain duplication, and may incorrectly classify preventive versus diagnostic services. A person screened in another system may be coded as unscreened, and a service merely ordered may be mistaken for completed. Validation should compare ascertainment sources where feasible, characterize migration and insurance changes, and describe limitations in data linkage Andersen (1995) Proctor et al. (2011).
A complete outcome architecture separates reach, acceptance, initiation, specimen adequacy, clinical completion, follow-up after abnormal findings, repeated adherence, experience, and health effects. Measures of choice quality and distress may accompany these behavioral endpoints. These dimensions should not be collapsed into an unexplained composite simply to improve apparent performance. The strongest studies designate a primary endpoint in advance and use secondary outcomes to trace mechanisms and potential unintended effects O'Connor (1995) Glasgow et al. (1999).
Results should be presented using interpretable absolute differences, denominator counts, intervals, and populations. Relative effects can be valuable, but a large relative increase from a very low baseline may still leave most eligible people unserved. Conversely, small percentage-point increases in a very large population may represent important service gains. Statistical significance should be interpreted together with equity, clinical appropriateness, implementation cost, and the likelihood that effects persist when trial support ends Liu et al. (2024) Proctor et al. (2011).
Causal Inference in Preventive Service Research
The causal question is whether an intervention changes an outcome that would otherwise have occurred under a credible comparison condition. Randomization offers protection against both measured and unmeasured baseline confounding when conducted and analyzed appropriately, but causal interpretation still depends on allocation procedures, missing outcomes, deviations from assigned conditions, contamination, and consistent measurement. Cluster-randomized designs, often needed for provider training or clinic workflows, require analysis that accounts for shared clinic-level influences and sufficiently many independent units Brewer, Hall, et al. (2017) Green et al. (2013).
Observational studies are essential for describing real-world patterns of service use and for detecting inequity. They are more vulnerable to selection when people who seek preventive care differ in socioeconomic resources, prior health behaviors, disease risk, or access to clinicians. Higher screening rates among patients receiving a particular reminder may reflect the algorithm's selection of reachable patients rather than the effect of the reminder itself. Regression adjustment can reduce measured confounding, but a causal conclusion additionally requires a plausible comparison, correct temporal ordering, and scrutiny of unmeasured factors Andersen (1995) Janz and Becker (1984).
Pragmatic trials can bring evaluation close to service-delivery conditions by randomizing real patients or clinics and recording outcomes through ordinary systems. Their external validity remains conditional: a trial in an integrated system with reliable mail, electronic records, and colonoscopy capacity may not transport to a fragmented system. Mechanistic analysis can separate whether participation changed through increased information, reduced effort, reminders, or follow-up assistance, but only if those mediators are measured and their causal assumptions are defensible. The clearest conclusion of a bundled pragmatic trial often concerns the entire intervention package Gupta et al. (2013) Pretsch et al. (2023).
Selection processes require particular scrutiny in self-sampling studies. Eligibility criteria, volunteering, consent return, and post-randomization exclusions define the population about which effects are estimated. The MBMT-3 trial's observed uptake effect is substantial under its tested intervention and comparison, while extrapolation to people who would not enroll or who face different postal and service conditions remains an additional question. Trial reporting should include selection, allocation, attrition, adherence, and analysis populations rather than displaying the headline effect alone Pretsch et al. (2023).
Systematic reviews aggregate evidence at the study level, but aggregation cannot repair consistently weak measurement or heterogeneous eligibility. Meta-analytic results should be interpreted in light of inclusion criteria, study design, intervention comparability, baseline risk, inconsistency, small-study effects, and publication bias. A scoping review maps an evidence landscape and usually answers a different question from a meta-analysis that computes a pooled effect. This monograph uses both forms as sources of context and synthesis without claiming to have independently conducted either procedure Liu et al. (2024) Kigongo et al. (2026).
Implementation Science and Service-System Performance
An effective intervention can fail when the service system cannot adopt or sustain it. Implementation science examines the conditions under which evidence-based practices become part of routine care. Proctor and colleagues distinguished implementation outcomes such as acceptability, adoption, appropriateness, feasibility, fidelity, implementation cost, penetration, and sustainability from clinical and service outcomes. These distinctions help identify whether low preventive uptake results from poor intervention content, inadequate rollout, insufficient reach, or breakdown after adoption Proctor et al. (2011).
The RE-AIM framework examines reach, effectiveness, adoption, implementation, and maintenance. Applied to screening outreach, reach asks what fraction of eligible people and which subgroups actually received the intervention; effectiveness concerns the measured benefits and harms; adoption asks which clinics or clinicians implemented it; implementation describes fidelity and adaptation; maintenance addresses whether services and effects persist. A program can have strong uptake among reached patients while leaving a large share of the eligible population uncontacted or losing effectiveness after research funding ends Glasgow et al. (1999).
Workflows are observable scientific objects. Registry accuracy, referral routing, laboratory turnaround, appointment capacity, translation quality, and escalation after positive results influence whether patients complete preventive episodes. Operational research can audit these processes with timestamps, queue data, direct observation, staff interviews, and patient reports. Connecting process measures to outcomes permits a diagnosis more informative than declaring that the population is insufficiently motivated Singal et al. (2017) Levesque et al. (2013).
Implementation cost is frequently underreported relative to participation. The relevant costs include staff hours, navigation, test processing, unsuccessful contact attempts, referral capacity, and required follow-up. A low-cost text intervention may be efficient when vaccination is already available at a scheduled visit, while a mailed-test program may require laboratory and diagnostic resources. Comparing interventions solely by the number of people responding to an invitation can misallocate funds when subsequent stages differ in expense or clinical value Milkman et al. (2021) Proctor et al. (2011).
A scientifically useful program evaluation connects implementation outcomes to clinical endpoints through an explicit causal pathway. For example, successful outreach increases testing, high-quality follow-up converts detected abnormalities into timely management, and effective management contributes to clinical benefit. Each connection requires appropriate evidence. Implementation success does not prove the downstream clinical effect of a screening test, and clinical efficacy does not guarantee population reach. Keeping these relationships separate makes quality improvement accountable WHO Regional Office for Europe (2020) Glasgow et al. (1999).
Equity, Context, and the Distribution of Preventive Opportunity
Preventive services are distributed through institutions, and inequality can enter at any point from eligibility identification to follow-up. Income, geography, disability, language, work schedules, housing stability, insurance arrangements, and historical treatment by institutions may shape both exposure to invitations and the chance of completing care. These conditions do not necessarily act through personal motivation. When a screening invitation reaches only registered, digitally connected patients, the intervention may improve mean uptake while leaving structurally excluded people invisible to the denominator Levesque et al. (2013) Penchansky and Thomas (1981).
Equity analysis requires specifying the relevant disparity, the comparison groups, and the desired criterion of fairness. Equal service offer is different from equal practical access; equal test completion is different from equal clinical need or equal informed decision quality. A uniform strategy may be less effective for a group facing greater transportation or language barriers, making tailored modes of invitation and support scientifically justified. Such tailoring should be assessed for its actual effect and patient acceptability rather than based on crude assumptions about demographic groups Andersen (1995) Kigongo et al. (2026).
The randomized trials of colorectal screening in safety-net systems show that organized outreach can reach groups underserved by opportunistic visit-based care. The cervical self-collection trial demonstrates that a different testing modality and delivery channel can improve uptake in a defined low-income, underscreened sample. Both findings suggest that reducing logistical demands is a plausible avenue for narrowing some gaps. Neither, by itself, demonstrates elimination of structural inequity, because broader distribution and long-term pathways were not equivalent across all populations Gupta et al. (2013) Pretsch et al. (2023).
A convincing equity evaluation reports intervention reach for the entire target population, the composition of those contacted, uptake and follow-up across prespecified relevant groups, and absolute as well as relative differences. It also investigates whether differential missing records, nonresponse, or movement between services can bias comparisons. Small subgroups may be underpowered for precise effect estimates; exploratory findings should therefore motivate further studies rather than be treated as settled group-specific truths Glasgow et al. (1999) Liu et al. (2024).
International research requires particular attention to the surrounding health system. Out-of-pocket expense, appointment structures, primary care coverage, national screening invitations, regional laboratory capacity, and regulatory authorization for self-collection vary across jurisdictions. A service-delivery package tested in one country can be adapted to another only after establishing clinical appropriateness, logistical feasibility, and local priorities. The causal target should be a reproducible function—such as reliable invitation or accessible specimen collection—rather than an uncritically copied organizational form WHO Regional Office for Europe (2020) Levesque et al. (2013).
Ethical Research, Privacy, and the Burden of Follow-Up
Preventive programs collect sensitive information about eligibility, test results, clinical history, contact details, and sometimes reproductive or genetic risk. Outreach systems must justify which information is necessary, who can access it, whether recipients consented to particular communication channels, and how confidentiality is maintained. A seemingly benign reminder may reveal sensitive health information if displayed on a shared phone or sent to the wrong address. Privacy practices are part of service quality and may influence willingness to engage with care Levesque et al. (2013) Proctor et al. (2011).
A service that encourages testing assumes a corresponding duty to provide understandable results and clinically appropriate next steps. In the case of an abnormal screening result, delay or lost follow-up may impose avoidable anxiety and undermine the intervention's purpose. Programs should measure communication timeliness, referral completion, and care continuity alongside screening rates. The ethically relevant outcome includes what happens to a patient after the point at which a dashboard records a successful test Gupta et al. (2013) Singal et al. (2017).
Respect for informed decisions also governs behavioral experiments. Randomized message framing can be acceptable when it promotes an appropriate service through accurate information and ordinary care channels; communications that conceal meaningful risks or manipulate fear can impair autonomy. Decision-support evaluations may use understanding, uncertainty, and values alignment as outcomes. The goal is a valid decision made under accessible conditions, not automatic acquiescence to a target participation rate O'Connor (1995) WHO Regional Office for Europe (2020).
The burdens of a screening program extend beyond direct clinical adverse effects. People may lose paid work, arrange childcare, travel repeatedly, experience stress while waiting for results, or receive unnecessary assessments after false positives. A cost-effectiveness analysis that examines only service costs overlooks patient time and social opportunity costs. These burdens can also have unequal effects across households, making their measurement relevant both for causal understanding and distributive fairness Penchansky and Thomas (1981) Welch and Black (2010).
Critical Comparison of Explanatory Models and Intervention Evidence
No single established framework fully explains preventive service uptake. The Health Belief Model identifies salient interpretations of risk and benefit, but its variables cannot by themselves account for whether clinics offer appointments or mail functional tests. Planned behavior highlights intentions and perceived control but requires supplementary explanation for the gap between intention and stage-by-stage action. Social cognitive theory describes confidence and self-regulation, while COM-B offers a practical classification of capabilities, opportunities, and motivations. Access frameworks identify the reciprocal fit between persons and services; implementation science identifies adoption and quality within organizations. These bodies of work are most useful when their distinct causal levels remain visible Janz and Becker (1984) Ajzen (1991) Bandura (2004) Michie et al. (2011) Levesque et al. (2013).
A scientifically productive synthesis begins by assigning each proposed determinant to a location in the pathway. Perceived benefit can influence acceptance after a valid invitation; transportation influences arrival; specimen return logistics influence test completion; laboratory capacity influences result delivery; specialist availability influences diagnostic follow-up. Some determinants operate across stages, and their effects can depend on other conditions. The relevant empirical task is to specify conditional hypotheses with observable endpoints rather than attributing the entire pathway to a single attitude or broad construct Penchansky and Thomas (1981) Singal et al. (2017).
The randomized trial literature supports intervention packages that reduce friction and strengthen clinical pathways, but the outcomes require careful separation. Gupta and colleagues showed a substantial increase in one-year colorectal screening with mailed outreach, whereas Singal and colleagues, using a three-year complete-process measure in another setting, found a different ranking between offered methods. Self-collection trials support improved cervical screening participation under specific eligibility and delivery conditions. Vaccination experiments show that provider communication and well-timed reminders can alter administration. These results coexist because they answer different clinical and behavioral questions Gupta et al. (2013) Singal et al. (2017) Pretsch et al. (2023) Brewer, Hall, et al. (2017) Milkman et al. (2021).
Evidence synthesis must resist publication-centered narratives. Positive trials can overrepresent easily measured outcomes, well-resourced institutions, and participants already reachable through electronic records. Interventions may have short follow-up, rely on self-report, or bundle several components whose individual effects are uncertain. A trial that detects a meaningful change in service use need not have the duration or power to measure disease-specific mortality. Reviewers should report these limits directly rather than treating them as reasons to ignore well-identified behavioral effects Liu et al. (2024) Kigongo et al. (2026) Krogsbøll et al. (2019).
The distinction between uptake effectiveness and clinical effectiveness is the central scientific constraint. Uptake evidence establishes whether an offer changes participation in a named service. Clinical evidence establishes whether the service itself improves outcomes, for which a different research architecture may be required. Quality assurance evaluates whether the intervention is performed safely and accurately. Ethical assessment asks whether people retain understandable options and agency. A program merits durable public support when these dimensions are evaluated together rather than substituted for one another WHO Regional Office for Europe (2020) Welch and Black (2010) Glasgow et al. (1999).
Unresolved Scientific Questions and Research Priorities
A major unresolved question concerns the durability of service-delivery interventions. Many studies evaluate a first test, a first vaccine dose, or a short uptake window; fewer demonstrate how effects persist across recurring invitations, repeated testing, population mobility, organizational turnover, and changing clinical recommendations. Longitudinal pragmatic trials should report participation trajectories and follow-up failures at each clinically meaningful stage, with data sufficient to distinguish maintained behavior from episodic responses to intensive outreach Singal et al. (2017) Green et al. (2013).
Another challenge is identifying mechanisms within multi-component interventions. When a mailed test plus telephone assistance raises screening completion, the combined causal effect is useful, but the separate contributions of convenience, personalized contact, trust, and reduced administrative burden remain uncertain. Factorial randomization, embedded process evaluations, and prespecified mediator measurements could clarify which functions are necessary for different populations. These designs should retain enough service capacity that an apparently weak psychological intervention is not merely constrained by a downstream bottleneck Michie et al. (2011) Gupta et al. (2013).
Equity demands better denominators and richer context. Research should ask who was eligible but absent from registries, who never received an invitation, who lacked a usable return address or phone, who required interpretation, and who was lost after a positive result. Differences in average uptake may conceal widening inequalities when interventions are easier for already connected patients to use. Studies should prespecify important distributional comparisons, retain sufficient statistical power, and supplement quantitative measures with appropriately designed qualitative investigation of the actual barriers Levesque et al. (2013) Glasgow et al. (1999) Kigongo et al. (2026).
Clinical appropriateness must be continuously re-evaluated. New technologies can increase diagnostic sensitivity and participation while also altering false-positive rates, overdiagnosis, cost, or the burden of follow-up. A program should not automatically treat an additional diagnosis or test as proof of benefit. Future research needs linked outcomes tracking through diagnosis, treatment, patient experience, and meaningful morbidity or mortality, together with transparent evaluation of harms and resource trade-offs WHO Regional Office for Europe (2020) Welch and Black (2010) Krogsbøll et al. (2019).
Trust, comprehension, and decision quality are further open fields. Studies can compare accurate numerical explanations, decision aids, communication by familiar clinicians, outreach through community organizations, and institution-level improvements in reliability. Measurement should separate knowledge, autonomy, concern, institutional trust, and observable participation. In preference-sensitive decisions, the expected outcome is an informed action appropriate to the person's values and clinical circumstances, which may include declining an intervention O'Connor (1995) Berkman et al. (2011).
Digital Systems, Artificial Intelligence, and the Artificial Era
Digital scheduling, reminders, registries, electronic records, and automated communication extend the operational capacity of preventive health systems. Their most demonstrable contribution is often coordinating a predictable next action: identifying an eligible patient, offering a service, reminding someone near an appointment, or tracing a missing follow-up step. The existing vaccination megastudy provides evidence for the narrower claim that particular text messages changed influenza vaccination behavior in its setting. It does not establish that automated decision systems can safely determine clinical eligibility without human and institutional oversight Milkman et al. (2021) Proctor et al. (2011).
Artificial systems may support preventive-service research through multilingual explanation, personalized appointment coordination, verification of follow-up completion, or examination of where a pathway fails. These are prospective applications requiring task-specific validation. Clinical recommendation engines face a distinct evidentiary burden: they must represent up-to-date guidance, person-specific risk, contraindications, uncertainty, privacy requirements, and referral capacity. A plausible response generated by a model is not equivalent to a verified clinical decision. Evaluation should therefore compare system outputs against qualified clinical standards and real-world outcomes before claims of benefit WHO Regional Office for Europe (2020) Levesque et al. (2013).
The Artificial Era adds a further research question about agency in care coordination. When an artificial system drafts reminders, classifies eligibility, offers translated explanations, or escalates abnormal results, the service pathway distributes cognitive work among patients, clinicians, institutions, and software. The outcome is observable in error rates, successful completion, comprehension, response latency, and accountability. A philosophical account of Artificial as a new historical order may guide interpretation of these arrangements, but claims about psychological mechanisms or clinical effectiveness still require operational definitions and independent empirical testing. The present monograph treats that horizon as an explicit future research domain, separate from demonstrated intervention outcomes Proctor et al. (2011) Michie et al. (2011).
Algorithmic outreach carries distributional and informational risks. A system trained on prior clinic attendance may rank people with stable records as more reachable, thereby systematically overlooking the least connected. Generated health explanations may present outdated screening criteria or obscure the balance of benefit and harm. Predictive tools can also expose sensitive health information through incorrect routing or overbroad access. Scientific evaluation needs audits for calibration, coverage across relevant groups, recommendation validity, security, accessibility, and adverse effects, alongside comparative tests of service completion Glasgow et al. (1999) WHO Regional Office for Europe (2020).
The most productive application is a bounded coordination function with transparent oversight: verified eligibility criteria, an auditable clinical knowledge source, patient-controlled communication preferences, accessible channels, human review of consequential decisions, and documented follow-up. Such architecture converts theoretical possibilities into testable hypotheses. Its success should be evaluated against conventional care for both appropriate access and safety, with separate reporting of downstream outcomes. This approach positions artificial participation within a broader accountable health system instead of presuming clinical competence from technical sophistication Proctor et al. (2011) Levesque et al. (2013).
Integrated Scientific Synthesis
The combined evidence supports a multilevel account of preventive service uptake. Clinical epidemiology first establishes whether an intervention should be offered to a specified population. Psychological processes shape how the offer is noticed, understood, trusted, and evaluated. Access conditions determine whether a favorable decision can be translated into action. Clinical workflow determines whether the service and necessary follow-up are completed. Implementation capacity determines whether the pathway works beyond the trial and reaches the intended population fairly. These dimensions form an empirical research program rather than a claim that one mechanism governs every preventive encounter WHO Regional Office for Europe (2020) Michie et al. (2011) Levesque et al. (2013) Proctor et al. (2011).
The most persuasive behavioral evidence is intervention-specific. Organized colorectal outreach increases observed testing relative to usual care in randomized studies, but one-time participation and full longitudinal completion yield different comparisons. Offering a validated cervical self-collection option with scheduling support increases uptake in an identified underscreened population. Provider communication and timely text reminders can improve administration of particular vaccines in studied settings. Systematic reviews broaden the evidence base but leave substantial contextual heterogeneity. This convergence supports practical service redesign as a major route to improved appropriate uptake Gupta et al. (2013) Singal et al. (2017) Pretsch et al. (2023) Brewer, Hall, et al. (2017) Milkman et al. (2021) Liu et al. (2024).
The strongest boundary condition is the quality of the preventive service itself. Increased participation is valuable insofar as an intervention is clinically appropriate, capable of reducing meaningful harm or improving health, and delivered with acceptable burdens and safeguards. The absence of a mortality benefit from undifferentiated general health checks in the Cochrane synthesis and the scientific problem of overdiagnosis prevent any unqualified inference from more screening to better health. Equitable access, informed choice, program fidelity, and downstream clinical results are coequal dimensions of a robust evaluation Krogsbøll et al. (2019) Welch and Black (2010) WHO Regional Office for Europe (2020).
Future knowledge will depend on research designs that connect decision mechanisms to verified pathway events and clinically consequential outcomes. The highest-value studies will measure eligibility and reach accurately, use credible counterfactual comparisons, trace repeated episodes, report effects across structurally disadvantaged groups, account for program resources, and test digital coordination under independent safety standards. An integrated science of preventive care thus combines behavioral explanation with clinical validity and accountable institutions Glasgow et al. (1999) Proctor et al. (2011) Kigongo et al. (2026).
Conclusion
Preventive Care, Screening, and Health Service Uptake is a coherent psychological and health-services research field centered on the realization of clinically appropriate preventive care through actual people and institutions. Its central phenomenon is a longitudinal, multistage pathway involving awareness, understanding, choice, access, completion, communication, and continuing care. Each stage has distinct determinants and measurable outcomes. Psychological beliefs and intentions matter within this pathway, while the distribution of service opportunity, institutional trustworthiness, practical burdens, and continuity of care determine whether intentions can be realized.
Historical health behavior models established the scientific relevance of perceived risk, benefits, barriers, norms, and self-efficacy. Access theory and implementation science made visible the conditions under which behavior occurs. Randomized trials of colorectal outreach, cervical self-collection, and vaccination reminders demonstrate that changing how an evidence-based service is delivered can change observed uptake. Longitudinal evidence additionally shows why a completed initial action and a completed preventive pathway are scientifically different outcomes Janz and Becker (1984) Levesque et al. (2013) Gupta et al. (2013) Singal et al. (2017) Pretsch et al. (2023) Milkman et al. (2021).
A completed screening test or vaccination encounter is an important service outcome, but the net value of prevention requires the quality and applicability of the underlying clinical evidence, informed agency, equitable access, safe follow-up, and health-related outcomes. A field that measures only uptake will systematically miss unfinished pathways and the burdens of inappropriate testing. The decisive direction for future research is to establish causal links among psychological decision processes, service architecture, sustained program quality, and measurable clinical benefit WHO Regional Office for Europe (2020) Krogsbøll et al. (2019) Proctor et al. (2011).
The Artificial Era extends this inquiry to distributed systems in which people, clinicians, and artificial agents participate in scheduling, explanation, monitoring, and service coordination. Its scientific promise is defined by independently demonstrated accuracy, accountability, accessibility, and clinical consequences. The durable contribution of this monograph is an evidence-grounded synthesis of prevention as a sequence of justified clinical offers and realized human actions within organized systems, providing an explicit foundation for future cross-disciplinary research.
References
- Ajzen, I. (1991). The theory of planned behavior. Organizational Behavior and Human Decision Processes, 50(2), 179–211. https://doi.org/10.1016/0749-5978(91)90020-T
- Andersen, R. M. (1995). Revisiting the behavioral model and access to medical care: Does it matter? Journal of Health and Social Behavior, 36(1), 1–10. https://pubmed.ncbi.nlm.nih.gov/7738325/
- Bandura, A. (2004). Health promotion by social cognitive means. Health Education & Behavior, 31(2), 143–164. https://doi.org/10.1177/1090198104263660
- Berkman, N. D., Sheridan, S. L., Donahue, K. E., Halpern, D. J., & Crotty, K. (2011). Low health literacy and health outcomes: An updated systematic review. Annals of Internal Medicine, 155(2), 97–107. https://doi.org/10.7326/0003-4819-155-2-201107190-00005
- Brewer, N. T., Chapman, G. B., Rothman, A. J., Leask, J., & Kempe, A. (2017). Increasing vaccination: Putting psychological science into action. Psychological Science in the Public Interest, 18(3), 149–207. https://doi.org/10.1177/1529100618760521
- Brewer, N. T., Hall, M. E., Malo, T. L., Gilkey, M. B., Quinn, B., & Lathren, C. (2017). Announcements versus conversations to improve HPV vaccination coverage: A randomized trial. Pediatrics, 139(1), e20161764. https://doi.org/10.1542/peds.2016-1764
- Glasgow, R. E., Vogt, T. M., & Boles, S. M. (1999). Evaluating the public health impact of health promotion interventions: The RE-AIM framework. American Journal of Public Health, 89(9), 1322–1327. https://doi.org/10.2105/AJPH.89.9.1322
- Green, B. B., Wang, C.-Y., Anderson, M. L., Chubak, J., Meenan, R. T., Vernon, S. W., & Fuller, S. (2013). An automated intervention with stepped increases in support to increase uptake of colorectal cancer screening: A randomized trial. Annals of Internal Medicine, 158(5 Pt 1), 301–311. https://doi.org/10.7326/0003-4819-158-5-201303050-00002
- Gupta, S., Halm, E. A., Rockey, D. C., Hammons, M., Koch, M., Carter, E., Valdez, L., Tong, L., Ahn, C., Kashner, M., Argenbright, K., Tiro, J., Geng, Z., Pruitt, S., & Skinner, C. S. (2013). Comparative effectiveness of fecal immunochemical test outreach, colonoscopy outreach, and usual care for boosting colorectal cancer screening among the underserved: A randomized clinical trial. JAMA Internal Medicine, 173(18), 1725–1732. https://doi.org/10.1001/jamainternmed.2013.9294
- Janz, N. K., & Becker, M. H. (1984). The Health Belief Model: A decade later. Health Education Quarterly, 11(1), 1–47. https://doi.org/10.1177/109019818401100101
- Kigongo, E., Heaney, C., McBride, L., Gliga, G., & Burns, R. M. (2026). A global scoping review of interventions to increase participation in screening programmes for breast, cervical and colorectal cancer between 2016 and 2025. BMC Public Health, 26, Article 2549. https://doi.org/10.1186/s12889-026-27893-1
- Krogsbøll, L. T., Jørgensen, K. J., & Gøtzsche, P. C. (2019). General health checks in adults for reducing morbidity and mortality from disease. Cochrane Database of Systematic Reviews, 2019(1), CD009009. https://doi.org/10.1002/14651858.CD009009.pub3
- Levesque, J.-F., Harris, M. F., & Russell, G. (2013). Patient-centred access to health care: Conceptualising access at the interface of health systems and populations. International Journal for Equity in Health, 12, Article 18. https://doi.org/10.1186/1475-9276-12-18
- Liu, S., Durantini, M. R., Calabrese, C., Sanchez, F., & Albarracin, D. (2024). A systematic review and meta-analysis of strategies to promote vaccination uptake. Nature Human Behaviour, 8, 1689–1705. https://doi.org/10.1038/s41562-024-01940-6
- Michie, S., van Stralen, M. M., & West, R. (2011). The behaviour change wheel: A new method for characterising and designing behaviour change interventions. Implementation Science, 6, Article 42. https://doi.org/10.1186/1748-5908-6-42
- Milkman, K. L., Patel, M. S., Gandhi, L., Graci, H. N., Gromet, D. M., Ho, H., Kay, J. S., Lee, T. W., Akinola, M., Beshears, J., Bogard, J. E., Buttenheim, A., Chabris, C. F., Chapman, G. B., Choi, J. J., Dai, H., Fox, C. R., Goren, A., Hilchey, M. D., ... Duckworth, A. L. (2021). A megastudy of text-based nudges encouraging patients to get vaccinated at an upcoming doctor's appointment. Proceedings of the National Academy of Sciences, 118(20), e2101165118. https://doi.org/10.1073/pnas.2101165118
- O'Connor, A. M. (1995). Validation of a decisional conflict scale. Medical Decision Making, 15(1), 25–30. https://doi.org/10.1177/0272989X9501500105
- Penchansky, R., & Thomas, J. W. (1981). The concept of access: Definition and relationship to consumer satisfaction. Medical Care, 19(2), 127–140. https://doi.org/10.1097/00005650-198102000-00001
- Pretsch, P. K., Spees, L. P., Brewer, N. T., Hudgens, M. G., Sanusi, B., Rohner, E., Miller, E., Jackson, S. L., Barclay, L., Carter, A., Wheeler, S. B., & Smith, J. S. (2023). Effect of HPV self-collection kits on cervical cancer screening uptake among under-screened women from low-income US backgrounds (MBMT-3): A phase 3, open-label, randomised controlled trial. The Lancet Public Health, 8(6), e411–e421. https://doi.org/10.1016/S2468-2667(23)00076-2
- Proctor, E., Silmere, H., Raghavan, R., Hovmand, P., Aarons, G., Bunger, A., Griffey, R., & Hensley, M. (2011). Outcomes for implementation research: Conceptual distinctions, measurement challenges, and research agenda. Administration and Policy in Mental Health and Mental Health Services Research, 38(2), 65–76. https://doi.org/10.1007/s10488-010-0319-7
- Rosenstock, I. M. (1974). Historical origins of the Health Belief Model. Health Education Monographs, 2(4), 328–335. https://doi.org/10.1177/109019817400200403
- Singal, A. G., Gupta, S., Skinner, C. S., Ahn, C., Santini, N. O., Agrawal, D., Mayorga, C. A., Murphy, C., Tiro, J. A., McCallister, K., Sanders, J. M., Bishop, W. P., Loewen, A. C., & Halm, E. A. (2017). Effect of colonoscopy outreach vs fecal immunochemical test outreach on colorectal cancer screening completion: A randomized clinical trial. JAMA, 318(9), 806–815. https://doi.org/10.1001/jama.2017.11389
- US Preventive Services Task Force. (2021). Screening for colorectal cancer: US Preventive Services Task Force recommendation statement. JAMA, 325(19), 1965–1977. https://doi.org/10.1001/jama.2021.6238
- Welch, H. G., & Black, W. C. (2010). Overdiagnosis in cancer. Journal of the National Cancer Institute, 102(9), 605–613. https://doi.org/10.1093/jnci/djq099
- World Health Organization, Regional Office for Europe. (2020). Screening programmes: A short guide. Increase effectiveness, maximize benefits and minimize harm. World Health Organization. https://www.who.int/publications/i/item/9789289054782